Clinical research professionals deeply desire greater diversity among study participants, but correcting underrepresentation of minority populations is not a quick fix. Both immediate interventions and long-term strategies are needed to foster and sustain real change.
Gena Pemberton, Vice President of DEI for Omnicom Health Group, will moderate a panel discussion with patient engagement experts about making changes that really matter to diverse patients.
Join a panel of experts as they discuss:
- DEI learnings from other industries and other areas of health communications can be applied to clinical trial engagement
- DEI barriers overcome in COVID-19 clinical trials
- Large pharma and study sites are approaching inclusivity
Speakers

Jameka Hill
Director, Diversity & Inclusion Lead
Moderna
Director, Diversity & Inclusion Lead
Moderna

Miaesha Campbell,
Director, Patient Recruitment,
Medpace
Director, Patient Recruitment,
Medpace

Charlita Whitehead
Patient Liaison NIAID
MMG
Patient Liaison NIAID
MMG

Marco Zurita
Patient Liaison NIAID
MMG
Patient Liaison NIAID
MMG

Gena Pemberton
Vice President of DEI
Omnicom Health Group
Vice President of DEI
Omnicom Health Group
PANEL MODERATOR